Please assess the completion status of the following clinical trial:

Trial Title: Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Recipient Inclusion Criteria:~1. Adult patients \> or = 18 years of age~2. Actively listed for Liver Transplant (LT) or Simultaneous Liver and Kidney (SLK)~3. Current HCV NAT- status~4. Review by multi-disciplinary transplant team that patient is appropriate for listing for HCV NAT+ liver offers~Recipient Exclusion Criteria:~1. Unwilling to consent to post transplant DAA therapy~2. Hepatitis B Virus (HBV) viremia~Donor Inclusion Criteria:~1. HCV NAT+~2. Deceased Donor organs~3. HBV cAb donors will be considered on a case by case basis based on specific recipient factors and plan for post-transplant prophylaxis~Donor Exclusion Criteria:~1. Bilirubin \>3~2. Positive nucleotide testing for HBV~3. Radiographic, laboratory or other clinical evidence of portal hypertension~4. Fibrosis on pre-procurement liver biopsy fibrosis \> F1 or fibroscan \>7 (if both are done and discordant, use biopsy to determine eligibility

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients who received a HCV+ liver transplant (Type: None): Patients on a wait list for a liver transplant who agree to receiving a hepatitis C+ virus positive tested liver transplant.
- Patients who received a HCV- liver transplant (Type: None): Patients on a wait list for a liver transplant who agree to receiving a hepatitis C- virus positive tested liver transplant.

Based on this trial design, predict the completion outcome and termination type (if applicable).